ClinicalTrials.Veeva

Menu
C

Coastal Connecticut Research | New London, CT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Estradiol
Enobosarm
fezolinetant
GTx-024
Troriluzole
Vibegron
Guanfacine HCl
Dapagliflozin
Florbetapir
Leuco-methylthioninium Bis(Hydromethanesulfonate)

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 34 total trials

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compul...

Enrolling
Obsessive-Compulsive Disorder
Drug: Placebo
Drug: Troriluzole

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Enrolling
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

Trial sponsors

G
Astellas logo
Biohaven logo
Shire logo
T
T
U
Viatris logo
W
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems